RNA breakthroughs, Case Studies and Partnerships
September 23-25, 2026Hynes Convention Center David WeinbergCEO at ParcelBioSpeaker
Profile
David Weinberg is the co-founder and CEO of ParcelBio. He was previously VP of RNA Platform at Orbital Therapeutics / Circ Bio, where he led the development of a circular RNA therapeutics platform. Before that, he was Senior Director of Molecular Research at Freenome, where he built the multiomics diagnostics platform that enabled a blood test for the early detection of cancer. David obtained his PhD from MIT, was a UCSF Faculty Fellow, and has been honored with Forbes ‘30 Under 30’, NIH Early Independence Award, and Biocom Life Science Catalyst Award.
Agenda Sessions
APEXm™ (Amplified and Prolonged EXpression mRNA) is a modular linear mRNA platform for potent and durable therapeutic protein expression
, 9:15amView Session